General Forum, page-6

Thanks for the suggestion! I'll be sure to read through that. I do like to read reports on companies that weren't actually made by the company itself because with the ones that were I tend to find that they are always upbeat about their progress (as they should) even when they shouldn't be and sometimes they can use vague sentences that imply something is better than it is. That's just a general thought, not on CardieX itself though.

Those 2023 predictions look steady, very bright if you applied a x30-x40 P/E ratio, but in the shorter term, I'm keen to see how many products they can launch this year, that will have a big impact on the share price. And as we all know, the share price jumps into overvalued territory on good news.